Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-19

FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approves Accord Healthcare's supplemental application to market quetiapine fumarate as a generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine fumarate (Quetiapine fumarate)

Snippet

SUPPL AP for QUETIAPINE FUMARATE (QUETIAPINE FUMARATE)